A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers
Completed
ChiRhoClin, Inc.
Phase 3
2007-10-01
The following are the study hypothesis:
- Secretin administration compared to placebo will result in a statistically significantly
greater percentage of collected fluid samples being predominantly of exocrine pancreas
origin when samples are duodenal aspirates.
- Secretin administration compared to placebo will result in a statistically significantly
greater percentage of collected fluid samples meeting the minimum specifications for use
in the indicated laboratory test of DNA mutational analysis.
Secretin Infusion for Pain Due to Chronic Pancreatitis
Completed
Dartmouth-Hitchcock Medical Center
Phase 1/Phase 2
2010-12-01
- To determine if intravenous secretin administration in escalating doses three times
daily for three days will improve the pain from CP at the time of infusion, after each
infusion (1 to 3 hours), at Day 7 after infusion, and at Day 30 after infusion.
- To validate the safety of intravenous secretin administration at the dosage indicated in
this study.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
